日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary Vascular Disease: An Official Statement of the Pulmonary Vascular Research Institute Exercise and Right Ventricular Function Task Force

关于心肺运动试验在肺血管疾病评估中的知识空白和争议:肺血管研究所运动与右心室功能工作组的官方声明

Waxman, Aaron B; Babu, Abraham; Badagliacca, Roberto; Ferreira, Eloara; George, Patty; Guazzi, Marco; Howard, Luke; Kim, Darlene; Kovacs, Gabor; Kubba, Saad; Langleben, David; McCabe, Colm; Menezes, Thais; Oliveira, Rudolf; Orfanos, Stylianos; Singh, Inderjit; Systrom, David; Tedford, Ryan; Vanderpool, Rebecca; Vizza, Carmine Dario; Rischard, Franz P

Ineffectiveness of Sotatercept Therapy in a Patient With Heritable Pulmonary Arterial Hypertension Associated With a Previously Unreported Missense Variant in GDF2, the Gene for Bone Morphogenic Protein-9

索他西普治疗对一名患有遗传性肺动脉高压的患者无效,该患者携带先前未报道的GDF2基因(骨形态发生蛋白-9基因)错义变异。

Langleben, David; Lesenko, Lyda; Fox, Benjamin D; Eintracht, Shaun; Foulkes, William D; Rosenblatt, David S

Disrupting BMP/TGF-β Signaling: Modulation of AQP1 and TGFB1 in Human Pulmonary Microvascular Endothelial Cells

干扰 BMP/TGF-β 信号通路:调节人肺微血管内皮细胞中的 AQP1 和 TGFB1

Keskinidou, Chrysi; Lotsios, Nikolaos S; Papavassiliou, Kostas A; Papavassiliou, Athanasios G; Dimopoulou, Ioanna; Kotanidou, Anastasia; Langleben, David; Orfanos, Stylianos E; Vassiliou, Alice G

Medication adherence and clinical outcome in patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension

药物依从性与肺动脉高压或远端慢性血栓栓塞性肺动脉高压患者的临床结局

Reimann, Lena; Preiss, Helga; Müller, Julian; Huber, Pascale; Mayer, Laura; Langleben, David; Ulrich, Silvia; Lichtblau, Mona

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study

肺动脉高压患者从肠外前列腺素类药物过渡到口服司来帕格:一项多中心回顾性队列研究

Budhram, Brandon; Alrasheed, Sarah K; Rashad, Moaaz; Chandy, George; Dvorkin-Gheva, Anna; Fox, George A; Foxall, Julia; Gardner, Andrea; Helmersen, Doug; Hirani, Naushad; Kemp, Kristina; Kularatne, Mithum; Langleben, David; Lesenko, Lyda; Provencher, Steeve; Spence, Emma; Swiston, John R; Thakrar, Mitesh; Wadden, Daniel; Weatherald, Jason; Hambly, Nathan

Management of pulmonary hypertension in special conditions

特殊情况下肺动脉高压的管理

Preston, Ioana R; Howard, Luke S; Langleben, David; Lichtblau, Mona; Pulido, Tomas; Souza, Rogerio; Olsson, Karen M

Transpulmonary Plasma Endothelin-1 Arterial:Venous Ratio Differentiates Survivors from Non-Survivors in Critically Ill Patients with COVID-19-Induced Acute Respiratory Distress Syndrome.

肺内血浆内皮素-1动脉:静脉比值可区分COVID-19诱发急性呼吸窘迫综合征危重患者的存活者和非存活者

Vassiliou Alice G, Roumpaki Anastasia, Keskinidou Chrysi, Athanasiou Nikolaos, Tsipilis Stamatios, Jahaj Edison, Vrettou Charikleia S, Giannopoulou Vassiliki, Halioti Asimenia, Ferentinos Georgios, Dimopoulou Ioanna, Kotanidou Anastasia, Langleben David, Orfanos Stylianos E

Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

利奥西呱与肺动脉高压和慢性血栓栓塞性肺动脉高压患者的右心室

Benza, Raymond L; Langleben, David; Hemnes, Anna R; Vonk Noordegraaf, Anton; Rosenkranz, Stephan; Thenappan, Thenappan; Hassoun, Paul M; Preston, Ioana R; Ghio, Stefano; Badagliacca, Roberto; Vizza, Carmine D; Lang, Irene M; Meier, Christian; Grünig, Ekkehard

Pulmonary capillary recruitment and distention in mammalian lungs: species similarities

哺乳动物肺部毛细血管募集和扩张:物种相似性

Langleben, David; Fox, Benjamin D; Orfanos, Stylianos E; Giovinazzo, Michele; Catravas, John D

The Paradox of Pulmonary Vascular Resistance: Restoration of Pulmonary Capillary Recruitment as a Sine Qua Non for True Therapeutic Success in Pulmonary Arterial Hypertension

肺血管阻力的悖论:恢复肺毛细血管募集是肺动脉高压真正治疗成功的必要条件

Langleben, David; Orfanos, Stylianos E; Fox, Benjamin D; Messas, Nathan; Giovinazzo, Michele; Catravas, John D